Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bauman

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A productionDavid R Bauman, Andrew D Bitmansour, Jeffrey G McDonald, et al.
Journal of Cancer Research and Clinical Oncology|June 16, 2022
Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapyJ Nicholas Bodor, Jessica R Bauman, Elizabeth A Handorf, et al.
Head & Neck|May 13, 2022
Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancerKevin K Zarrabi, Thomas J Galloway, Douglas B Flieder, et al.
Future Oncology (London, England)|April 24, 2025
Order of treatment with ALK inhibitors and its effect on people with lung cancer in the real world: a plain language summaryJessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Mefloquine induces dose-related neurological effects in a rat modelG Dow, R Bauman, D Caridha, et al.
Oral Oncology|July 10, 2017
Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancerYanqun Dong, John A Ridge, Tianyu Li, et al.
Biochimica Et Biophysica Acta|August 3, 2010
Non-stereo-selective cytosolic human brain tissue 3-ketosteroid reductase is refractory to inhibition by AKR1C inhibitorsStephan Steckelbroeck, Dieter Lütjohann, David R Bauman, et al.
Molecular and Cellular Endocrinology|January 19, 2006
Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitorsTrevor M Penning, Stephan Steckelbroeck, David R Bauman, et al.
Journal of Palliative Medicine|September 15, 2016
End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor MutationsJessica R Bauman, Zofia Piotrowska, Alona Muzikansky, et al.
Oral Oncology|July 27, 2019
Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancerYanqun Dong, John A Ridge, Barbara Ebersole, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A productionDavid R Bauman, Andrew D Bitmansour, Jeffrey G McDonald, et al.
Journal of Cancer Research and Clinical Oncology|June 16, 2022
Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapyJ Nicholas Bodor, Jessica R Bauman, Elizabeth A Handorf, et al.
Head & Neck|May 13, 2022
Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancerKevin K Zarrabi, Thomas J Galloway, Douglas B Flieder, et al.
Future Oncology (London, England)|April 24, 2025
Order of treatment with ALK inhibitors and its effect on people with lung cancer in the real world: a plain language summaryJessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Mefloquine induces dose-related neurological effects in a rat modelG Dow, R Bauman, D Caridha, et al.
Oral Oncology|July 10, 2017
Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancerYanqun Dong, John A Ridge, Tianyu Li, et al.
Biochimica Et Biophysica Acta|August 3, 2010
Non-stereo-selective cytosolic human brain tissue 3-ketosteroid reductase is refractory to inhibition by AKR1C inhibitorsStephan Steckelbroeck, Dieter Lütjohann, David R Bauman, et al.
Molecular and Cellular Endocrinology|January 19, 2006
Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitorsTrevor M Penning, Stephan Steckelbroeck, David R Bauman, et al.
Journal of Palliative Medicine|September 15, 2016
End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor MutationsJessica R Bauman, Zofia Piotrowska, Alona Muzikansky, et al.
Oral Oncology|July 27, 2019
Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancerYanqun Dong, John A Ridge, Barbara Ebersole, et al.
Pageof 11